Drugs / OCHROMYCINONE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01047943 | Jun 2007 → Apr 2008 | psoriasis | Kochi University | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OCHROMYCINONE | ChEMBL registry synonym — accepted as the source's own label CHEMBL256705 ↗ |
| Known as | J655.169F | ChEMBL registry synonym — accepted as the source's own label CHEMBL256705 ↗ |
| Known as | STA-21 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01047943 ↗ |
| Action | Inhibit | “Since STA-21 inhibits Stat3 activation” NCT01047943 ↗ |
| Modality | Small molecule | “a small Stat3 inhibitor” PMID 20811392 ↗ Sep 2010 |
| Route | Topical | “topical application of 0.2% STA-21 in Vaseline” NCT01047943 ↗ |
| Target | STAT3 | “Since STA-21 inhibits Stat3 activation” NCT01047943 ↗ |